In conjunction to the change in the leadership of Episurf Medical (NASDAQ: EPIS B) January 5 2017, Dennis D. Stripe assumed the position as Executive Chairman. Following the appointment of Pål Ryfors as CEO on June 2 2017, Dennis D. Stripe now re-assume to role as non-executive Chairman.
“Episurf Medical is making steady progress and as our clinical results continue to be very promising, we are positioning ourselves for a very interesting future in the orthopaedic industry, and I look forward to take part in this development”, says Dennis D. Stripe.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.